Vico Therapeutics

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for central nervous system diseases, initially focusing on SCA (spinocerebellar ataxia), HD (Huntington's disease), and RETT syndrome (a neurodevelopmental disorder that primarily affects girls).